PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

Tue, 24th Oct 2023 17:08

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

London equities were in the red around midday, unlike European peers, as the banking sector weighed on the FTSE 100 following less-than-stellar results from Barclays.

The FTSE 100 index closed up 14.87 points, 0.2%, at 7,389.70. The FTSE 250 ended down 64.89 points, 0.4%, at 16,994.10, and the AIM All-Share closed down 1.96 points, 0.3%, at 678.45.

The Cboe UK 100 ended up 0.2% at 737.16, the Cboe UK 250 closed down 0.5% at 14,738.75, and the Cboe Small Companies ended down 0.2% at 12,692.94.

In European equities, the CAC 40 in Paris ended up 0.6%, while the DAX 40 in Frankfurt ended up 0.5%.

The US private sector saw moderate expansion in October, following largely stagnant output in September and August, according to the latest flash estimate from S&P Global.

The headline S&P Global US purchasing managers' index rose to 51.0 in October, from 50.2 in September. Rising above the 50.0 no-change mark, it signalled a modest up-tick in business activity in the month.

S&P Global said the upturn was supported by expansions in activity for manufacturers and service providers alike. It noted that demand conditions for manufacturers improved for the first time since April, while service providers witnessed a slower drop in new orders.

The flash US manufacturing PMI stood at 50.0 in October, up fractionally from 49.8 in September. The flash US services business activity index stood at 50.9, up from 50.1 last month.

Both flash estimates were better than expected by markets. The sectors had been expected to remain in contraction territory, according to FXStreet-cited consensus.

The dollar gained ground in the wake of the print.

The pound was quoted at USD1.2163 at the London equities close on Tuesday in London, lower compared to USD1.2226 on Monday. The euro stood at USD1.0588, lower against USD1.0639. Against the yen, the dollar was trading at JPY149.90, higher compared to JPY149.79.

Stocks in New York were higher at the London equities close, with the DJIA up 0.6%, the S&P 500 index up 0.6%, and the Nasdaq Composite up 0.7%.

Coca-Cola was up 2.6% in New York at the London close.

The Atlanta, Georgia-based soft drink maker said revenue in the three months to September 29 increased 8.0% on-year to USD11.95 billion from USD11.06 billion. Net income was 9.2% higher at USD3.08 billion from USD2.82 billion.

Coca-Cola now expects organic revenue growth between 10% and 11% in 2023, having previously predicted a rise between 8% and 9%. It now expects comparable currency neutral earnings per share growth of 13% to 14%, lifted from its previous growth range of 9% to 11%.

"Being one of the strongest brands in the world, Coca-Cola's got plenty of staying power, and there's a lot to be said for that in an uncertain environment," said Hargreaves Lansdown analyst Aarin Chiekrie.

Investors also reacted to signs of a cooling UK economy in the latest PMI data.

The S&P Global/CIPS flash UK flash composite PMI rose slightly to 48.6 points in October from 48.5 in September. However, sitting below the 50.0 no change mark, the latest reading suggests the private sector remains in decline.

Looking ahead, S&P said concerns about the outlook for business and consumer spending meant that output growth expectations for the year ahead were the lowest since December 2022.

"Observers will take some comfort from the fact that PMIs do not account for the whole economy, although last week's lacklustre retail sales figures (which are excluded from PMIs) are not especially encouraging," said Handelsbanken analyst Daniel Mahoney.

The unemployment rate for the period for June to August was estimated at 4.2%. This was a 0.2 percentage point increase compared with the period from March to May, the the Office for National Statistics said.

The ONS explained that the figures are an "alternative series of estimates", due to "increased uncertainty" around the Labour Force Survey estimates.

Last month, the ONS said unemployment stood at 4.3% in the three months ended July.

In the FTSE 100, Rio Tinto was the top performer, rising 3.5%, after Barclays raised its rating for the London-based mining company to 'overweight' from 'equal weight'.

AstraZeneca was the second-best performer, rising 3.4% and building on Monday's gains from its Enhertu treatment being approved by the European Commission to treat adult lung cancer patients.

On Tuesday, the Cambridge-based pharmaceutical firm said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine.

The US Food & Drug Administration accepted the drugmaker's supplemental biologics licence application for the needle-free nasal spray. It expects a regulatory decision on the product during the first quarter of 2024. If approved then, FluMist is expected to be available in the US for the 2024/2025 flu season.

If the product is reviewed, it will be the first flu vaccine available to be self-administered, "adding an additional option to be vaccinated against influenza".

Barclays was the second-worst performing FTSE 100 stock, losing 6.5%.

For the quarter that ended September 30, the bank's total income rose 5.2% on-year to GBP6.26 billion from GBP5.95 billion a year prior. However, the figure fell short of the GBP6.29 billion company-compiled consensus.

Barclays reported pretax profit of GBP1.89 billion for the quarter, down 4.3% on-year from GBP1.97 billion. However, it beat the company-compiled market consensus of GBP1.77 billion.

Looking ahead, Barclays backed its annual return on tangible equity forecast of "greater than 10%".

However, it trimmed UK net interest margin guidance. It now expects this to land around "3.05% to 3.10% in 2023".

In a negative read-across, rival banks NatWest and Lloyds Banking were down 1.9% and 1.4%, respectively.

Bunzl lost 4.0% after the distribution firm said revenue in the third-quarter of the year declined by 4.8% at constant exchange rates.

Bunzl put the revenue fall to a "continued decline in Covid-19 related product sales" and a lesser benefit from inflation. It also said there was a "wider post-pandemic related normalisation trends which drove expected volume weakness".

In the FTSE 250, CAB Payments was by far the worst performer, with its shares plunging 72%.

The cross-border payments and foreign exchange firm now expects annual revenue to be "at least" 20% ahead of the GBP109.4 million achieved in 2022. This is about 17% below its previous guidance, however.

It expects the "majority of any revenue impact" will hit its bottom line but will be seeking opportunities to lessen the impact on its bottom line.

Softcat was the second-worst FTSE 250 performer, falling 12%. This was despite reporting "another record year", the IT infrastructure and services provider said.

It reported a pretax profit of GBP141.9 million for the year ended July 31, up 4.2% from GBP136.1 million the year prior. Revenue dropped 8.6% to GBP985.3 million from GBP1.08 billion.

The decline was primarily driven by its Hardware segment, which saw revenue drop 24% year-on-year to GBP610.6 million. Meanwhile, revenue for its Software and Services segments grew 26% and 43%, respectively.

Elsewhere in London, FD Technologies lost 33% after the County Down, Northern Ireland-based group said it swung to a pretax loss of GBP4.5 million in the six months that ended August 31 from a profit of GBP1.1 million a year earlier.

Revenue fell to GBP142.5 million from GBP147.4 million, while it said it expects financial 2024 revenue in the range of GBP285 million to GBP295 million, from GBP296.0 million a year earlier.

Brent oil was lower at USD86.37 a barrel at the London equities close on Tuesday from USD91.05 late Monday. Gold was lower at USD1,963.03 from USD1,977.60.

In Wednesday's UK corporate calendar, a slew of trading statements are released, including by Fresnillo, Ibstock, Lloyds Banking and Reckitt Benckiser.

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.